Of note, 67% to 97.8% of patients with immune TTP have detectable ADAMTS13 antibodies; however, a small percentage may not have any detectable antibodies [2,7]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.